COSMOS Pharmaceutical Corporation
CSMYF · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $42,372 | $24,454 | $32,773 | $33,048 |
| Dep. & Amort. | $22,229 | $19,924 | $17,368 | $15,110 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$8,567 | $7,437 | $10,164 | -$1,203 |
| Other Non-Cash | -$3,567 | $3,360 | -$5,871 | -$14,761 |
| Operating Cash Flow | $52,467 | $55,175 | $54,434 | $32,194 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$53,326 | -$55,810 | -$46,636 | -$43,497 |
| Net Acquisitions | $0 | $0 | $46 | $1,519 |
| Inv. Purchases | $0 | $0 | -$500 | -$713 |
| Inv. Sales/Matur. | $0 | $0 | $428 | $407 |
| Other Inv. Act. | -$2,122 | -$1,519 | -$2,451 | -$1,433 |
| Investing Cash Flow | -$55,448 | -$57,329 | -$49,113 | -$43,717 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $14,918 | $15,207 | $8,372 | -$1,186 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$2 | $0 | $0 | -$2 |
| Dividends Paid | -$4,959 | -$4,659 | -$3,266 | -$3,266 |
| Other Fin. Act. | -$2,240 | -$2,021 | -$1,861 | -$1,768 |
| Financing Cash Flow | $7,717 | $8,527 | $3,245 | -$6,222 |
| Forex Effect | $0 | $0 | $0 | -$1 |
| Net Chg. in Cash | $4,737 | $6,373 | $8,566 | -$17,746 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52,301 | $45,928 | $37,362 | $55,108 |
| End Cash | $57,038 | $52,301 | $45,928 | $37,362 |
| Free Cash Flow | -$859 | -$635 | $7,798 | -$11,303 |